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Themetabolic property of skeletal muscle adapts in response
to an increased physiological demand by altering substrate uti-
lization and gene expression. The calcium-regulated serine/
threonine protein phosphatase calcineurin has been implicated
in the transduction ofmotor neuron signals to alter gene expres-
sion programs in skeletal muscle. We utilized transgenic mice
that overexpress an activated form of calcineurin in skeletal
muscle (MCK-CnA*) to investigate the impact of calcineurin
activation on metabolic properties of skeletal muscle. Activa-
tion of calcineurin increased glucose incorporation into glyco-
gen and lipid oxidation in skeletalmuscle. Activated calcineurin
suppressed skeletal muscle glucose oxidation and increased lac-
tate release. The enhancement in lipid oxidation was supported
by increased expression of genes for lipidmetabolism andmito-
chondrial oxidative phosphorylation. In a reciprocal fashion,
several genes of glycolysis were down-regulated, whereas pyru-
vate dehydrogenase kinase 4 was markedly induced. This
expression pattern was associated with decreased glucose utili-
zation and enhanced glycogen storage. The peroxisome prolif-
erator-activated receptors (PPARs) and PPAR coactivator 1
(PGC1) are transcription regulators for the expression of met-
abolic and mitochondrial genes. Consistent with changes in the
gene-regulatory program, calcineurin promoted the expression
of PPAR, PPAR, and PPAR coactivator 1 in skeletal mus-
cle. These results provide evidence that calcineurin-mediated
skeletal muscle reprogramming induces the expression of sev-
eral transcription regulators that coordinate changes in the
expression of genes for lipid and glucose metabolism, which in
turn alters energy substrate utilization in skeletal muscle.
The metabolic property of skeletal muscle is highly flexible
and adapts to various physiological demands by altering energy
substrate utilization (1, 2). Skeletal muscle can be classified into
two categories based on the distinct metabolic and contractile
activity: fast glycolytic fibers that derive energy primarily from
glycolysis for sudden rapidmovement and slow oxidative fibers
that rely mainly on oxidation of energy substrates for sustained
recurring activity. Although such diversity has been long rec-
ognized, the cellular mechanisms that regulate skeletal muscle
metabolic properties remain largely elusive.
Signals from the motor neurons are critical factors in regu-
lating the metabolic properties of skeletal muscle (3, 4).
Chronic low frequency electrical stimulation of skeletal muscle
(resembling the firing pattern of slowmotor neurons) activates
the expression of Lpl (lipoprotein lipase) (5), Cd36 (fatty acid
transporter) (6), Had (hydroxyacyl-CoA dehydrogenase) (7),
and Cs (citrate synthase) (7, 8). Furthermore, the expression of
Glut4 (glucose transporter 4) and activity of Hk2 (hexokinase
2), two proteins that are essential for glucose uptake and stor-
age, are increased in skeletal muscle after electrical stimulation
(9). Although electrical stimulation represents an artificial
model of contractile activity-inducedmotor neuron activity (3),
thismodel provides evidence that signals evoked bymotor neu-
rons can induce substantial changes in metabolic gene expres-
sion profiles in skeletal muscle.
Calcineurin is a calcium-regulated serine/threonine protein
phosphatase implicated in the transduction of calcium signals
elicited by the motor neurons to the myofibers (10–12). Cal-
cineurin dephosphorylates nuclear factor of activated T cell
transcription factors and promotes their translocation into the
nucleus for transcription of target genes of the slow fiber pro-
gram (10). Transgenic mice expressing activated calcineurin in
fast glycolytic skeletalmuscle have increased expression of slow
contractile machinery, including troponin I and slow myosin
ATPase (13). Conversely, pharmacological inhibition of cal-
cineurin activity induces a slow to fast myosin ATPase trans-
formation in rat soleus muscle (10). In addition, several tran-
scription factors and coactivators have been implicated in the
metabolic adaptation of skeletalmuscle.Overexpression of per-
oxisome proliferator-activated receptor  (PPAR)3 in skeletal
muscle increases the expression of regulatory genes involved in
lipidmetabolism andmitochondrial oxidative phosphorylation
(14). Skeletal muscle-specific overexpression of PPAR coacti-
vator 1 (PGC1) (15) or activation of PPAR (16) drives the
formation of slow oxidative fibers, concomitant with increased
mitochondrial biogenesis.
We previously reported that activation of calcineurin
enhances glucose transport and insulin action in skeletal mus-
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cle (17). In this study, we investigated the impact of calcineurin-
mediated skeletal muscle reprogramming on the energy sub-
strate utilization and determined whether calcineurin induces
metabolic adaptations via coordinated changes in gene expres-
sion. We tested the hypothesis that calcineurin activates the
slow fiber gene regulatory program by activating PPAR,
PPAR, and PGC1.
EXPERIMENTAL PROCEDURES
TransgenicMice—Aline of transgenicmice expressing a con-
stitutively active form of calcineurin (18) driven by skeletal
muscle creatine kinase promoter/enhancer was established at
the Karolinska Institutet, using MCK-CnA* mice (a kind gift
from Dr. Eric N. Olson) that were originally developed at the
Department of Molecular Biology, University of Texas South-
western Medical Center at Dallas (13). Female MCK-CnA*
mice andwild-type littermatesweremaintained on a 12-h light-
dark cycle and allowed free access to water and standard rodent
chow. Mice were anesthetized via intraperitoneal injection of
2.5% avertin (0.02ml/g of bodyweight), and extensor digitorum
longus (EDL) and soleus muscles were removed for in vitro
incubation or expression analysis. We studied EDL and soleus
muscles because they display different contractile and meta-
bolic properties. EDLmuscles fromwild-typemice contain pre-
dominantly fast twitch fibers and 2% type I (slow oxidative)
fibers, whereas soleus muscles are composed of 50% type I
fibers, with the remaining percentage attributed mainly to type
IIa (fast oxidative) fibers (19). The mice were humanely killed
by cervical dislocation immediately after muscle dissection.
The Ethics Committee on Animal Research in Northern Stock-
holm approved all experimental procedures.
RNA Purification and cDNA Synthesis—EDL was homoge-
nized in 800l of Trizol reagent (Sigma), and RNAwas purified
according to recommendations of the manufacturer. Purified
RNA was then treated with DNase I, using a DNA-free kit
(Ambion, Huntingdon, Cambridgeshire, UK) according to the
manufacturer’s protocol. DNase-treated RNA was used as a
template for cDNA synthesis using the SuperScript first strand
synthesis system (Invitrogen) with oligo(dT) primers. A reac-
tionwithout reverse transcriptasewas included for each sample
to serve as reverse transcriptase-minus control.
Quantitative Real Time PCR—The quantity of cDNA for
each transcript wasmeasured using real time PCRwith the ABI
PRISM 7000 sequence detector system and fluorescence-based
SYBR-green technology (Applied Biosystems, Warrington,
UK). PCR was performed in a final volume of 25 l, consisting
of diluted cDNA sample, 1 SYBR-green PCR Master Mix
(Applied Biosystems), primers optimized for each target gene,
and nuclease-free water. All samples were analyzed in dupli-
cate. Relative quantities of target transcripts were calculated
fromduplicate samples after normalization of the data against a
housekeeping gene (acidic ribosomal phosphoprotein PO)
using the standard curve method. Primers were designed using
Primer Express computer software (Applied Biosystems).
Transcript sequences obtained from the ENSEMBL data base
were Cpt1 (carnitine palmitoyl-CoA transferase 1; ENS-
MUST00000023287), Cd36 (ENSMUST00000003024), Cs (cit-
rate synthase;ENSMUST00000005826),Hadsc (shortchainHAD;
ENSMUST00000029610), Lpl (ENSMUST00000015712), Pfkm
(muscle 6-phosphofructokinase; ENSMUST00000043950), Pdk4
(pyruvate dehydrogenase kinase 4; ENSMUST00000019721), and
sequences from theNCBIGenBankTMdata basewere acidic ribo-
somal phosphoprotein PO (BC003833), Aldoa (aldolase A;
NM007438), Cpt2 (NM009949), Decr1 (2,4-dienoyl-CoA reduc-
tase 1; NM026172), Gapdh (glyceraldehyde-3-phosphate dehy-
drogenase; BC095932), Ldh (lactate dehydrogenase; NM008492),
Slc25a20 (mitochondrial carnitine/acylcarnitine translocase;
NM020520), and Acadvl (very long chain acyl-CoA dehydro-
genase; NM017366).
Muscle Incubations—Incubation media were prepared from
stocks of pregassed (95% O2, 5% CO2) Krebs-Henseleit buffer
supplemented with 5 mM HEPES and 0.1% bovine serum albu-
min (radioimmunoassay grade). EDL and soleus muscle were
excised and incubated at 30 °C in a shaking water bath under a
constant gas phase (95% O2/5% CO2) unless stated otherwise.
Glucose Oxidation, Glucose Incorporation into Glycogen, and
Lactate Release—Muscles were incubated (30 °C for 60 min) in
1ml of Krebs-Henseleit buffer containing 8mM [U-14C]glucose
(0.3 Ci/ml) with or without insulin (12 nM). Vials were sealed
with a rubber stopper, whichwas fittedwith a center well.Mus-
cles were oxygenated for the first 60 min of the incubation
period via a needle inserted through the stopper. After 60 min,
muscles were removed from the vial, trimmed of excess tendon,
and weighed. Thereafter, 0.2 ml of Protosol (PerkinElmer Life
Sciences) was injected through the rubber stopper into the cen-
ter well, and the medium was acidified by injection of 0.5 ml of
15% perchloric acid. Liberated CO2 was collected for 60 min,
and center wells were transferred to vials for liquid scintillation
counting. Results were expressed as mmol of oxidized glu-
cose/g of wet weight/h. The rate of glucose incorporation into
glycogenwas determined by accumulation of 14C into glycogen.
The muscles were homogenized in 500 l of 1 M NaOH and
subsequently neutralized with 500 l of 20% trichloroacetic
acid. The homogenateswere centrifuged at 3500 g for 15min,
and the supernatant was collected. Glycogen of the supernatant
was precipitated by the addition of 200 l of 110 mM glycogen
and 2ml of 95% ethanol. The glycogen precipitate was collected
after centrifugation (2000  g for 15 min) and dissolved in
water for liquid scintillation counting. For the measurement of
lactate release, nonradiolabeled glucose was used. After 60 min
of incubation with or without insulin, medium was collected,
and the lactate concentrationwasmeasuredbyusing a colorimet-
ric lactate assay kit (Biomedical Research Service Center, Univer-
sity at Buffalo) according to themanufacturer’s instructions.
Oleate Oxidation—Muscles were trimmed of excess tendon
and weighed before preincubation for 40 min in Krebs-Hense-
leit buffer supplementedwith 5mMHEPES, 3.5% fatty acid-free
bovine serum albumin, 5 mM glucose, and 12 nM insulin. Mus-
cles were then transferred to vials containing 1 ml of identical
mediumwith the addition of 0.3mM [1-14C]oleate (0.2Ci/ml)
and incubated for 60min. Vials were sealed with a rubber stop-
per, which was fixed with a center well. Muscles were oxygen-
ated for the first 15 min of the incubation period via a needle
inserted through the stopper. Thereafter, the oxygen needle
was removed to close the system. After 60 min, 0.2 ml of Solv-
able (PerkinElmer Life Sciences) was injected through the rub-
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ber stopper into the center well, and 0.5 ml of 15% perchloric
acid was injected into the medium. Released CO2 was collected
for 60 min, and center wells were transferred to vials for liquid
scintillation counting after the addition of 47 l of 5 M HCl.
Results are expressed as nmol of oxidized oleate/g of wet
weight/h.
Western Blot Analysis—Muscles were pulverized in micro-
centrifuge tubes over liquid nitrogen and homogenized by a
motor-driven pestle in 0.3 ml of ice-cold lysis buffer containing
20 mM Tris (pH 8.0), 137 mM NaCl, 2.7 mM KCl, 10 mM NaF, 1
mM MgCl, 1 mM Na3VO4, 0.2 mM phenylmethylsulfonyl fluo-
ride, 10% glycerol, 1% Triton X 100, 1 g/ml aprotinin, and 1
g/ml leupeptin. Homogenates were solubilized by end-over-
end mixing at 4 °C for 60 min and subjected to centrifugation
for 10min at 12,000 g and 4 °C. Total proteinwas determined
using a commercially available kit (Pierce), and proteins (50g)
solubilized in Laemmli sample buffer were separated by SDS-
PAGE and transferred to Immobilon-P membranes (Millipore,
Bedford, MA). Western blot analysis was performed using the
following antibodies against actin (Cell Signaling), aldolase
(Biodesign, Saco,ME),HK2 (a kind gift fromO.Pedersen, Steno
Memorial Hospital, Gentofte, Denmark), PDK4 (Abgent, San
Diego, CA), PGC1 (Chemicon, Temecula, CA), GAPDH,
PPAR, and PPAR (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA). Antibodies against NADH-ubiquinol oxidoreduc-
tase, succinate-ubiquinol oxidoreductase, ubiquinol-cyto-
chrome c oxidoreductase subunit II, cytochrome c oxidase sub-
unit I, and ATP synthase  subunit were from Molecular
Probes, Inc. (Eugene, OR). Proteins were visualized by chemi-
luminescence and quantified by densitometry.
Statistical Analysis—Data are expressed asmeans S.E. Dif-
ferences among groupswere determined by two-way analysis of
variance followed by Fisher’s least significant differences post
hoc analysis. Differences between two groups were determined by
unpaired Student’s t test. Significance was accepted at p 0.05.
RESULTS
Rate of Glucose Incorporation into Glycogen and Glucose
Oxidation—The rate of glucose incorporation into glycogen
was determined in skeletal muscle from wild-type mice and
MCK-CnA* mice. In wild-type mice, insulin increased the rate
of glucose incorporation into glycogen 10.1- and 4.3-fold in
EDL and soleus muscles, respectively (Fig. 1A). Under insulin-
stimulated conditions, the rate of glucose incorporation into
glycogen was 98 and 34% greater in EDL and soleus muscles
from MCK-CnA* mice respectively, compared with wild-type
mice (Fig. 1A). Rates of glucose incorporation into glycogen of
soleus muscles were not significantly different between wild-
type and MCK-CnA* mice under the basal condition. Insulin
increased the rate of glucose oxidation 2.1-fold in EDLmuscles
fromwild-type mice (Fig. 1B). However, the effect of insulin on
glucose oxidation was blunted in EDL muscles from MCK-
CnA* mice (Fig. 1B). The basal and insulin-stimulated rate of
glucose oxidationwas not significantly different between soleus
muscles from wild-type and MCK-CnA* mice.
Regulatory Genes of Glucose Metabolism—In EDL muscles
from MCK-CnA* mice, mRNA abundance of Pfkm (42%),
Aldoa (33%), and Gapdh (24%) was reduced compared with
wild-type mice (Fig. 2). In contrast, mRNA abundance of Ldh
and Pdk4 was increased 210 and 340%, respectively, compared
withwild-typemice. Protein content ofHK2was increased 37%
in EDL muscles from MCK-CnA* mice, relative to wild-type
mice (Fig. 3A). In contrast, protein content of aldolase and
GAPDHwas down-regulated in EDLmuscles fromMCK-CnA*
mice 59 and 45% compared with wild-type mice (Fig. 3, B and
C). Expression of activated calcineurin in EDLmuscle increased
PDK4 protein content 260% compared with wild-type mice
(Fig. 3D). No significant change was observed for protein con-
tent of these enzymes in soleus muscle between wild-type and
MCK-CnA* mice.
Rate of Oleate Oxidation and Lactate Release—Rate of lipid
oxidation was determined in skeletal muscle from wild-type
FIGURE 1. Glucose metabolism in EDL muscle from MCK-CnA* mice. The
rates of glucose incorporation into glycogen (A) and glucose oxidation (B)
were assessed in EDL and soleus muscle from wild-type and MCK-CnA* mice
under basal (open bars) and insulin-stimulated (closed bars) conditions. Data
are means  S.E. for n  5–7 muscles. *, p  0.05; **, p  0.005 compared with
wild type.
FIGURE 2. Coordinated changes in expression of genes essential for glu-
cose metabolism in EDL muscle from MCK-CnA* mice. The level of mRNA
expression of genes essential for glucose metabolism in EDL muscle from
wild-type (open bars) and MCK-CnA* (closed bars) mice was determined by
real time PCR. Data are expressed as percentage of EDL muscle from wild-type
mice. Data are means  S.E. for n  8 –9 muscles. **, p  0.005 compared with
wild type.
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andMCK-CnA*mice.Oleate oxidationwas 41% greater in EDL
muscles of MCK-CnA* mice compared with wild-type mice
under the insulin-stimulated condition (Fig. 4A), consistent
with our previous finding of elevated basal oleate oxidation in
EDLmuscles fromMCK-CnA*mice (17). Insulin increased the
rate of lactate release in EDLmuscles fromwild-typemice 280%
(Fig. 4B). The basal and insulin-stimulated rate of lactate
release was increased in EDL muscles from MCK-CnA* mice
310 and 156% respectively, compared with wild-type mice (Fig.
4B). No significant further increase in lactate release was
observed in soleus muscle from MCK-CnA* mice, relative to
wild-type mice.
Regulatory Genes of Lipid and Mitochondrial Oxidative
Phosphorylation—Expression of activated calcineurin in EDL
skeletal muscle induced a consistent increase in the mRNA
level of regulatory genes for lipid metabolism. The mRNA level
of Lpl and Cd36 (genes involved in transport of lipid into the
myofiber) was elevated 185 and 116%, respectively, in MCK-
CnA*mice comparedwithwild-typemice (Fig. 5). Genes essen-
tial for transport of acyl-CoA into the mitochondria, including
Cpt1 (65%), Cpt2 (127%), and Slc25a20 (89%), were up-regu-
lated in EDL muscles from MCK-CnA* mice, compared with
wild-type mice. The mRNA abundance of mitochondrial
FIGURE 3. Changes in protein content of enzymes of glucose metabo-
lism in EDL muscle from MCK-CnA* mice. Protein content of HK2
(A), aldolase (B), GAPDH (C), and PDK4 (D) in EDL and soleus muscle of
wild-type and MCK-CnA* mice was determined by Western blot analysis
(equal sample loading was confirmed by blotting for actin). Data are
expressed as a percentage of EDL muscle from wild-type mice. Data are
means  S.E. for n  5– 6 muscles. *, p  0.05; **, p  0.005 compared with
wild type.
FIGURE 4. Lipid oxidation and lactate release in EDL muscle from MCK-
CnA* mice. EDL and soleus muscle from wild-type and MCK-CnA* mice
were incubated in the absence (open bars) or presence (closed bars) of
insulin, and oleate oxidation (A) or lactate release (B) was determined.
Data are means  S.E. for n  6 –7 muscles. *, p  0.05; **, p  0.005
compared with wild type.
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enzymes involved in oxidation of fatty acid, including Decr1
(113%), Acadvl (77%), Hadhsc (62%), and Cs (24%), were also
augmented in EDL muscle from MCK-CnA* mice compared
with wild-type mice.
Expression of activated calcineurin induced a marked
increase in protein content of mitochondrial proteins for
oxidative phosphorylation in EDL muscle from MCK-CnA*
mice relative to wild-type mice, including NADH-ubiquinol
oxidoreductase (193%), succinate-ubiquinol oxidoreductase
(27%), ubiquinol-cytochrome c oxidoreductase subunit II
(135%), cytochrome c oxidase subunit I (216%), and ATP
synthase  subunit (71%) (Table 1, Fig. 6). There was no
further increase in the protein expression of these genes in
soleus muscle of MCK-CnA* mice.
Induction of Transcription Factor and Co-activator by
Calcineurin—Protein content of PPAR (160%) and PPAR
(90%) was increased in EDL muscle from MCK-CnA* mice,
relative to wild-type mice (Fig. 7). Consistent with our pre-
vious finding (17), protein content of PGC1 was also
increased 191% in EDL muscle fromMCK-CnA* mice, com-
pared with the wild-type mice. Comparable levels of protein
content were observed in soleus muscle of MCK-CnA* and
wild-type mice.
DISCUSSION
Our results provide evidence that expression of activated cal-
cineurin in fast glycolytic skeletalmuscle induces amarked shift
in glucose and lipid metabolism. Moreover, insulin-induced
glucose oxidation was suppressed, concomitant with a coordi-
nated decrease in the expression of glycolytic enzymes (PFKM,
aldolase, and GAPDH) and an increase in the expression of
LDH and PDK4, a potent inhibitory enzyme for glucose oxida-
tion (20). The decrease in glucose oxidation was accompanied
by a striking increase in insulin-stimulated glucose incorpora-
tion into glycogen. This is consistent with our previous report
of increased expression ofGlut4 and glycogen synthase (17) and
our current finding of increased HK2 expression. Therefore,
expression of activated calcineurin in skeletal muscle reduces
the partitioning of glucose for oxidation but increases glucose
sparing for glycogen synthesis (supplemental Fig. S1). These
calcineurin-regulated metabolic changes are partly mediated
by coordinated changes in gene expression.
Lipid oxidation in EDL muscles from MCK-CnA* mice
under the insulin-stimulated condition was elevated compared
with wild-type mice, consistent with our previous report of
increased basal lipid oxidation (17). The enhanced capacity for
lipid oxidation and increased expression of PDK4 markedly
increased lactate release from EDL
muscle of MCK-CnA* mice under
basal and insulin-stimulated condi-
tions, further supporting decreased
entry of glucose into the Krebs
cycle. Therefore, expression of acti-
vated calcineurin induced a shift in
substrate metabolism from glucose
utilization to lipid oxidation in skel-
etal muscle.
The enhancement of lipid oxida-
tion in EDL muscle of MCK-CnA*
mice is supported by a consistent
increase in the expression of genes
involved in lipid metabolism. The
expression of Lpl and Cd36, two
FIGURE 5. Calcineurin-induced expression of genes essential for lipid metabolism. The level of mRNA
expression of genes critical for lipid metabolism in EDL muscle from wild-type (open bars) and MCK-CnA*
(closed bars) mice was determined by real time PCR. Cs, citrate synthase. Data are expressed as percentage
of EDL muscle from wild-type mice. Data are means  S.E. for n  8 –9 muscles. **, p  0.005 compared
with wild type.
TABLE 1
Protein content of enzymes involved in mitochondrial oxidative phosphorylation
Shown is protein content of enzymes involved in mitochondrial oxidative phosphorylation in EDL and soleus muscle from wild-type andMCK-CnA* mice, as determined
by Western blot analysis. Data are expressed as the percentage of EDL muscle from wild-type mice. Values (n  5–6) are reported as means  S.E. NS, not significant.
Wild type MCK-CnA* p value
% %
NADH-ubiquinol oxidoreductase
EDL 100  17 293  24 p  0.005
Soleus 351  20 341  14 NS
Succinate-ubiquinol oxidoreductase
EDL 100  6 127  11 p  0.05
Soleus 131  8 123  7 NS
Ubiquinol -cytochrome c oxidoreductase subunit II
EDL 100  4 235  12 p  0.005
Soleus 254  7 250  18 NS
Cytochrome c oxidase subunit I
EDL 100  10 316  34 p  0.005
Soleus 424  56 339  24 NS
ATP synthase  subunit
EDL 100  22 171  21 p  0.05
Soleus 176  22 179  14 NS
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genes required for the uptake of lipid from extracellular space
into themyofiber was up-regulated in EDLmuscle of the trans-
genic mice. The entry of lipid-derived acyl-CoA into the mito-
chondrial is facilitated by multiple genes, includingCpt1, Cpt2,
and Slc25a20, and expression of activated calcineurin increased
the mRNA level of these genes in support of lipid utilization.
Furthermore, several genes essential for -oxidation, namely
Decr1, Acadvl, and Hadhsc were also up-regulated in skeletal
muscle harboring activated calcineurin. In cultured primary
cardiac myocytes, activation of calcineurin induces the afore-
mentioned lipid metabolic genes (21), further underlining the
role of calcineurin in the regulation of lipid metabolic gene
expression. Therefore, activated calcineurin is sufficient to
increase the transcription of multiple enzymes important for
lipid metabolism to achieve a profound up-regulation of skele-
tal muscle lipid oxidation.
The expression of genes regulating lipid metabolism, includ-
ing Lpl, Cd36, Cpt1, Cpt2, Acadvl, and Hadhsc, as well as Pdk4
are regulated by PPAR (22). Consistent with the increase in
mRNA expression of these genes, expression of activated cal-
cineurin in skeletal muscle markedly increased the in vivo
expression of PPAR. Skeletal muscle-specific overexpression
of PPAR in mice also promotes the expression of Cd36, Cpt2,
Slc25a20, Decr1, Acadvl, Hadhsc, and Pdk4 (14). In cultured
C2C12 myotubes and cardiac myocytes, expression of Ppar is
directly induced by calcineurin via activation of the Ppar pro-
moter (21). Here, we provide evidence that activated cal-
cineurin induced the expression of PPAR, in support of lipid
oxidation via consistent increase in lipid metabolic gene
expression.
In addition to PPAR, PPAR has also been implicated as a
transcription regulator of skeletal muscle lipid metabolism.
Both PPAR subtypes have a redundant and compensatory func-
tion in the regulation of lipid oxidation and gene regulatory
events (23). We therefore cannot exclude the role of PPAR
(apart from PPAR) in mediating the effects of calcineurin on
lipid oxidation. The induction of lipid oxidation and metabolic
genes in human and rat cultured myotubes observed in
response to a selective PPAR agonist is similar to the effects
FIGURE 6. Calcineurin-induced increase in protein content of enzymes
involved in mitochondrial oxidative phosphorylation. Representative
immunoblot for protein content of NADH-ubiquinol oxidoreductase, succi-
nate-ubiquinol oxidoreductase, ubiquinol-cytochrome c oxidoreductase
subunit II, cytochrome c oxidase subunit I, and ATP synthase  subunit was
determined by Western blot analysis (equal sample loading was confirmed by
blotting for actin). Quantification of results is summarized in Table 1.
FIGURE 7. Protein content of PPAR, PPAR, and PGC1 in skeletal mus-
cle of MCK-CnA* mice. Protein content of PPAR (A), PPAR (B), and PGC1
(C) was determined in EDL and soleus muscle from wild-type and MCK-CnA*
mice (equal sample loading was confirmed by blotting for actin). Data are
expressed as percentage of EDL muscle from wild-type mice. Data are
means  S.E. for n  5– 6 muscles. *, p  0.05; **, p  0.005 compared with
wild-type.
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observed in response to a PPAR-selective agonist (23). More-
over, there was no additive effect on lipid oxidation and gene
expression when maximum doses of both agonists were used
concurrently, suggesting that both PPARs might bind to the
same response element within a particular promoter (23).
Moreover, starvation and exercise elicit an appropriate
response on skeletal muscle Pdk4 and Ucp3 expression in
PPAR knock-out mice. Given that the expression of skeletal
muscle Ppar is severalfold higher than Ppar, as well as the
finding that there is functional similarity between these two
transcription regulators, PPARhas been proposed to compen-
sate for the loss of PPAR in these mice (23). Consistently, in
vivo pharmacological activation of PPAR increases lipid oxi-
dation in skeletal muscle via induction of lipidmetabolic genes,
including Cpt1, Pdk4, and Ucp3 (24), a response that is also
achieved by activation of PPAR. Our results provide evidence
for the role of both PPAR and - in calcineurin-induced skel-
etal muscle lipid oxidation and metabolic gene expression.
NADH and FADH2 generated from -oxidation are reoxi-
dized via oxidative phosphorylation to produce ATP. Our
results show that expression of activated calcineurin is associ-
ated with increased lipid oxidation in skeletal muscle and a
concomitant increase in protein content of the mitochondrial
oxidative phosphorylation machinery. Skeletal muscle mito-
chondrial biogenesis is promoted by overexpression of either
PGC1 or activated PPAR. Overexpression of either PGC1
(15) or activated PPAR (16) in mouse skeletal muscle also
induces the formation of slow oxidative fibers. In transfected
cells, PGC1 coactivates the calcineurin-mediated activation of
myoglobin and troponin I gene promoter, suggesting a syner-
gistic effect of calcineurin and PGC1 on the activation of the
slow oxidative gene expression program (15). Furthermore, in
skeletal muscle of PGC1 knock-out mice, mitochondrial gene
expression (25, 26) and respiration (25) are impaired. Trans-
genic or pharmacological approaches to activated PPAR also
increase mitochondrial gene expression, including Cpt1 and
various Cox genes in skeletal muscle (16). However, the signal-
ing pathways that regulate the expression of these transcription
factors and coactivator are largely unresolved. Our results sup-
port the hypothesis that calcineurin inducesmitochondrial bio-
genesis via induction of PGC1 and PPAR expression.
Calcineurin has been proposed to play a role in the regulation
of exercise-induced gene expression in human skeletal muscle
(27–29). Exercise activates skeletal muscle calcineurin and
PGC1 expression (27–29), and this is correlated with mito-
chondrial biogenesis (29).However, inhibition of calcineurin by
cyclosporin treatment in rats did not abolish exercise-induced
mRNAexpression of PGC1 andmultiplemitochondrial genes
(30). The regulation of mitochondrial biogenesis in skeletal
muscle is complex and likely to involve additional signaling
pathways. For example, AMP-activated protein kinase and
myogenin (a muscle-specific transcription factor) have also
been proposed to mediate exercise-induced metabolic adapta-
tions. Activation of AMP-activated protein kinase in mice by
geneticmanipulation and pharmacological approaches induces
a similar pattern of exercise-induced gene expression (31, 32),
including lipidmetabolic genes (33, 34) andmitochondrial pro-
teins (35, 36) in skeletal muscle. In myogenin transgenic mice,
there is a shift from glycolytic to oxidative metabolism, con-
comitant with increased mitochondrial proteins in skeletal
muscle (37). Clearly, multiple signaling pathways and nuclear
effectors are involved in the regulation of the metabolic gene
expression program in skeletal muscle.
Our results support the hypothesis that calcineurin regulates
pathways controlling lipid and glucose metabolism in skeletal
muscle via coordinated changes in the expression of metabolic
genes, as well as transcription regulators, including PPAR,
PPAR, and PGC1. Furthermore, activation of calcineurin
markedly induced skeletal muscle mitochondrial biogenesis.
Therefore, we provide evidence that activated calcineurin alters
metabolic andmitochondrial gene expression as well as various
transcription regulators, leading to profound alterations in
skeletal muscle lipid and glucose metabolism.
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